Overview Recently Resected Patient Extending Adjuvant GLIVEC Recurrence Post Adjuvant Therapy Metastatic Patient With Progression After GI/Surgeon Diagnosis About GIST Expert Opinions
Print
Font size:

GIST IS A COMPLEX SARCOMA THAT REQUIRES A DIFFERENTIAL DIAGNOSIS1

Historically, GIST was a poorly characterized disease entity, frequently misdiagnosed as smooth muscle tumor.2

Research advances and implementation of new technologies have transformed our knowledge of GIST in terms of 3:

  • Cellular and molecular etiology
  • Diagnostic strategies
  • Treatment options

Multidisciplinary approach

There is also an increasing understanding that optimal management of GIST involves a multidisciplinary team, incorporating4:

  • Gastroenterology
  • Medical oncology
  • Pathology
  • Radiology
  • Surgery

Practitioners of these disciplines have vital roles to play throughout the process, including initial evaluation, management, and follow-up.


Mechanism of Disease/Action

Incidence and Diagnosis

Risk of Recurrence

Multidisciplinary Approach

New Tablet
and Packaging

Learn more

See how GLIVEC works in
KIT+ GIST

View this
informative
animation now

Visit Library and Tools
for access to more
in-depth information
and resources

Prescribing
GLIVEC

Learn more

GLIVEC Product
Characteristics

View more

GLIVEC Safety
and Tolerability

Learn more

GLIVEC and KIT+ GIST

Glivec and Ph+ CML

Glivec and Additional Indications

For Your Patients

Library and Tools